During yesterday’s trading session, the US dollar did not change a lot against a basket of major currencies. The dollar index (#DX) closed without changes (+0.00%). Investors are still focused on coronavirus in China. The death toll from pneumonia rose to 17 on Thursday with nearly 600 confirmed cases. Investors again drew attention to “safe haven” currencies amid this news.
The Bank of Canada decided on the key interest rate yesterday. As experts forecasted, the indicator remained unchanged at 1.75% per annum. At the same time, the regulator signaled a possible reduction in rates in the future. Today, we expect the ECB interest rate decision. We recommend paying attention to the comments by representatives of the Central Bank.
The demand for the Australian dollar has grown. During the Asian trading session, optimistic economic data have been published in Australia. Thus, the level of employment rose to 28.9K in December instead of 15.0K. The unemployment rate counted to only 5.1% and was below the forecasted value of 5.2%.
The “black gold” prices are declining. Currently, futures for the WTI crude oil are testing the $55.80 mark per barrel. At 18:00 (GMT+2:00), US crude oil inventories will be published.
Market Indicators
Yesterday, there was a variety of trends in the US stock market: #SPY (+0.01%), #DIA (-0.01%), #QQQ (+0.26%).
The 10-year US government bonds yield show negative dynamics. At the moment, the indicator is at the level of 1.74-1.75%.
The Economic News Feed for 23.01.2020:
– ECB interest rate decision at 14:45 (GMT+2:00);
– Initial jobless claims in the US at 15:30 (GMT+2:00).
The Transportation Index, a common measure of economic optimism or pessimism, collapsed very early in trading after the Martin Luther King holiday (January 20, 22020). We found this very informative because a rotation like this suggests optimism may be waning by global investors and future expectations of growing economic activity may be reverting to more realistic expectations headed into a US election year on top of the US political circus.
When we take a look at these TRAN charts, below, pay very special attention to the historical upper range of price activity over the past 20+ months and you’ll see why we believe a top formation/setup near these current levels in the TRAN could be a very strong topping pattern for the US and Global markets.
Daily Transportation Chart
This Daily Transportation chart highlights the immediate rotation that is setting up a sideways price channel. The range between 11,250 and 10,450 has established a moderately strong sideways price channel going back well over 3+ months in the Transportation Index. The broader price channel, between 11,250 and 9,700, extends well over 8+ months. Beyond that, we have a rotation going all the way back into 2018, between 11,600 and 8,650, that establishes a very broad sideways price channel.
The Transportation Index has been trading within this sideways price channel over the past 20+ months as global investors attempt to determine the future expectations for the US and global economies. If global investors believe the economy will accelerate as consumers become more active, then the Transportation Index will rise above the 11,800 level on an upside breakout move. If global investors believe the US and global economies will contract before experiencing any further advance, then the Transportation Index will likely fall to levels below 10,400 – possibly lower.
The recent downside rotation in the TRAN suggests global investors and skilled traders are not expecting the economy to continue as it has over the past 6 to 12+ months – as the US stock market. The melt-up in the US stock market was a result of global capital attempting to take advantage of a stronger US Dollar and continued price appreciation in the NASDAQ and various US stock sectors. Even though the underlying economic data and fundamentals may not have changed, it was still advantageous for global investors/traders to play the “melt-up” because it provided the opportunity to gain on two fronts – US Dollar gains and US share price gains.
If this massive “capital shift” trade is unwinding, in part or in full, then we will start to see weakness in the Transportation Index and likely the Mid-Caps as global investors try to pull away from risks in the US stock market. If the Transportation Index falls below 10,450, then we need to get ready for a potentially bigger downside price move across the global markets.
Weekly Transportation Chart
This Weekly TRAN chart highlights our Adaptive Fibonacci price modeling system which has drawn the GREEN and RED “trigger levels” above and below the current price action. It is doing this because the TRAN price action has not defined any real price trends recently – staying within the sideways price channel. The price must either rally above 11,450 to begin a new bullish price trend or fall below 8,990 to initiate a new bearish price trend. That means a downside price rotation may support a -2000 point decline from current levels before initiating a continued downside Bearish global market trend.
It is time to really start paying attention to what happens with the Transportation Index. First, we have to watch the 10,400 level. Then we have to watch the 9,700 level. If both of those fail, then we have to watch the 8,990 level as the final “trigger level” for a new global market bearish trend. We are a long way away from that moment right now, but it appears the Transportation Index has started to revert back to the downside and we are alerting our friends and followers to be aware this rotation may be a very timely warning of a new global market top in the making.
Utility Sector Warns of Big Money Is Exiting The Market
Utility stocks have been on fire ripping to the upside and they tend to lead precious metals and then bonds so I am starting to get excited for our portfolio.
We locked in 10% the 3rd quarter of our SSO position today, we still have 25% of that initial position left but our exposure to equities is now very small. All the other asset classes like high yield bonds, gold, and utilities are pointing to a correction in the stock market.
You can see which markets do well at various stages of risk in the market using our custom market gauge we have been developing. This is one of the new trading tools have been working on.
This gauge will automatically update live with the markets using all of our analyses. Its a really exciting new tool we plan to make available in the next 30 days for our subscribers.
BIG MONEY FLOW GAUGE 20-40 Day Market Price Cycle
TheTechnicalTraders.com Market Gauge
Join my Wealth Building Newsletter if you like what you read here and ride my coattails as I navigate these financial markets and build wealth while others lose nearly everything they own.
EUR/USD currency pair continues to trade in Flat. There is no defined trend is not observed. Currently, the local support and resistance levels are 1.10750 and 1.11000, respectively. Investors took to a waiting approach before the ECB meeting. It is expected that the regulator will keep the main monetary policy parameters at the same level. We recommend you to pay attention to the comments and rhetoric of the Central Bank representatives. Open positions from key levels.
At 14:45 (GMT+2:00) the ECB will announce its key interest rate.
Indicators do not give accurate signals: the price is consolidating near 50 MA and 100 MA.
MACD histogram is near the 0 mark.
The stochastic oscillator is located in the neutral zone, the %K line is below the %D line, which gives a sell signal for EUR/USD.
Trading recommendations
Support levels: 1.10750, 1.10400
Resistance levels: 1.11000, 1.11200, 1.11450
If the price fixes below 1.10750, further decline of EUR/USD quotes is expected to 1.10400-1.10200.
Alternatively, the EUR/USD currency pair may recover to 1.11200-1.11500.
The GBP/USD currency pair
Technical indicators of the currency pair:
Prev Open: 1.30450
Open: 1.31387
% chg. over the last day: +0.71
Day’s range: 1.31191 – 1.31509
52 wk range: 1.1959 – 1.3516
The GBP/USD currency pair is dominated by bullish sentiments. Yesterday the quotes growth exceeded 90 points. The trading instrument has set new local highs. The demand for sterling rose after the Confederation of British Industry reported about the strengthening of producer sentiment. According to Refinitiv, financial markets participants see a 50% chance of rate cuts compared to 70% on Monday. The meeting of the Bank of England is scheduled for next week. Currently, GBP/USD quotes are consolidated in the range 1.31000-1.31450. We do not rule out further strengthening of the pound against the US dollar. Open positions from key levels.
The Economic News Feed for 23.01.2020 is calm.
The indicators signal the strength of buyers: the price has fixed above 50 MA and 100 MA.
The MACD histogram is in the positive zone, but below the signal line, which gives a weak signal to buy GBP/USD.
The Stochastic Oscillator is located in the oversold area, the %K line crossed the %D line. There are no signals at the moment.
Trading recommendations
Support levels: 1.31000, 1.30750, 1.30350
Resistance levels: 1.31450, 1.32000
If the price fixes above 1.31450, expect further growth of GBP/USD quotes to the round level of 1.32000.
Alternatively, the quotes could decrease to 1.30700-1.30400.
The USD/CAD currency pair
Technical indicators of the currency pair:
Prev Open: 1.30712
Open: 1.31347
% chg. over the last day: +0.57
Day’s range: 1.31326 – 1.31716
52 wk range: 1.2949 – 1.3566
Aggressive purchases are observed on the USD/CAD currency pair. The looney has overcome and strengthened above the key extremums. Yesterday, Bank of Canada kept its key interest rate at 1.75% as expected, but opened the door for a possible decline in case of slow growth. Weak inflation data and negative dynamics of oil quotes put additional pressure on the Canadian dollar. We do not rule out further growth in the trading instrument. At the moment the key range is 1.31300-1.31700. Open positions from these marks.
Today the publication of important economic releases from Canada is not planned.
The indicators signal the strength of buyers: the price has fixed above 50 MA and 100 MA.
MACD histogram is in the positive zone, which gives a signal to buy USD/CAD.
The Stochastic Oscillator is in the neutral zone, the %K line is below the %D line, which indicates a possible correction of the USD/CAD currency pair.
Trading recommendations
Support levels: 1.31300, 1.31000, 1.30750
Resistance levels: 1.31700, 1.32000
If the price fixes above 1.31700, expect further growth toward 1.32000-1.32200.
Alternatively, the quotes could decine toward 1.31000.
The USD/JPY currency pair
Technical indicators of the currency pair:
Prev Open: 109.848
Open: 109.832
% chg. over the last day: -0.02
Day’s range: 109.503 – 109.856
52 wk range: 104.45 – 113.53
USD/JPY quotes have moved down. The trading instrument has updated the local lows. Investors started partially fixing USD positions after a long rally. Currently, USD/JPY is testing the support level at 109.500. The mark 109.700 is the nearest resistance. The trading instrument has a potential for further decline. We recommend you to pay attention to the dynamics of the US government bonds yield. Open positions from key levels.
Weak data on the trade balance of Japan was published during the Asian trading session.
The indicators signal the sellers’ strength: the price has fixed below 50 MA and 100 MA.
Histogram of MACD is in the negative zone, which indicates further correction of USD/JPY currency pair.
The Stochastic Oscillator is located in the oversold area, the %K line crossed the %D line. There are no signals at the moment.
Trading recommendations
Support levels: 109.500, 109.200, 109.000
Resistance levels: 109.700, 109.800, 110.000
If the price fixes below 109.500, expect further correction toward 109.300-109.100.
Alternatively, the quotes could grow toward 109.900-110.000.
Smaller than forecast Japanese trade deficit bearish for USDJPY
On 1-hour timeframe USDJPY: H1 is retracing higher toward the 200-period moving average MA(200) which is falling itself. However the stochastic indicator has formed a bullish divergence.
We believe the bullish momentum will resume after the price breaches above the fractal high at 109.62. A level above this can be used as an entry point for placing a pending order to buy. The stop loss can be placed below 109.42. After placing the order, the stop loss is to be moved to the next fractal low, following Parabolic signals. Thus, we are changing the expected profit/loss ratio to the breakeven point. If the price meets the stop loss level without reaching the order, we recommend cancelling the order: the market has undergone internal changes which were not taken into account.
Japan’s trade deficit widened less than expected to 100 billion yen in December 2019. Will the USDJPY start rising?
On Wednesday, January 22, the euro was up 0.09% at the close. A positive attitude towards the major currencies resulted from the growth of the GBP, which strengthened across the board on the back of positive economic data and news regarding Brexit.
The House of Lords of the UK Parliament approved the Brexit bill, meaning that on January 31, Great Britain will leave the European Union – all that is left is for the agreement to be ratified by the EU Parliament.
At the American session, pressure was exerted on the euro by data from the US real estate market, which exceeded forecasts and the previous results. House sales hit their highest figures in almost two years (5.4 million, the forecast was 5.35 million).
Today’s events (GMT+3):
15:45 Eurozone: ECB Interest Rate Decision.
16:30 Eurozone: ECB Monetary Policy Statement and Press Conference.
16:30 USA: Initial Jobless Claims (Jan 17).
18:00 Eurozone: Consumer Confidence (Jan).
18:30 USA: EIA Crude Oil Stocks Change (Jan 17).
Current situation:
Yesterday’s expectations came true. There is no forecast due to the ECB meeting and Christine Lagarde’s press conference, scheduled for later in the day. Investors are not quite used to her yet, so it is difficult to take into account the mood of the crowd when making a forecast.
In addition to the press conference, President Trump’s statement had a negative impact on the euro. In an interview with Fox News on Wednesday, he said that if the US and the EU do not reach an agreement on trade, Washington will impose a 25% duty on the import of European cars. There is also political uncertainty in Italy. The leader of the Five Star Movement, which forms part of the government, announced his resignation.
At the time of writing, the euro is worth 1.1091. The price is near the balance line (Lb). Euro crosses are showing mixed dynamics. If buyers can somehow gain a foothold above 1.11, then the road to 1.1122 will open for them. In any case, we wouldn’t advise making any forays into the market before the Lagarde press conference.
By Hussein Sayed, Chief Market Strategist (Gulf & MENA), ForexTime – The coronavirus has the world on alert. After the SARS epidemic killed nearly 800 people across 37 countries in 2003 causing a lot of panic and economic disruption along the way, there are serious concerns about another outbreak of a new coronavirus that has spread in Chinese cities, including the capital Beijing and Shanghai.
Currently, it’s unclear whether the existing outbreak constitutes a public health emergency of international concern, which requires a coordinated global response. However, when looking at financial assets’ behaviour, there are clear signs of investor scepticism.
Three weeks ago, the year kicked off with hopes that global activity would pick up after the US and China reached a trade truce and central banks showed no signs of tightening policy in the near future.
In this low yield environment, it has been wise to hold risk assets such as cyclical equities, especially as we have seen a steady improvement in US corporate earnings over the past week.
The argument against overweighting risk assets is that valuations are being overstretched, as many metrics for growth cyclical stocks have hit levels last seen in the late nineties “dot com” bubble. But given that investors’ required rate of return is relatively low compared to that period and there’s still a significant amount of cash on the sidelines, there has been nothing to stop the current uptrend in equities.
The question being asked now is whether the outbreak of the coronavirus is likely to be a catalyst for a market correction. Today’s reaction reminds us of early February 2018 when the CBOE Volatility index (VIX) jumped by a record 20 points in one day. That move was unexpected and led to a sharp sell-off in risk assets with the S&P 500 falling more than 8% five days after the VIX spike; although we note it took only 11 days to recover all these losses.
With travel now halted from the Chinese city Wuhan, investors fear that the virus has already spread across the country and probably around the world. Chinese stocks are leading the losses in Asian markets today with the Shanghai composite falling 2.85% at the time of writing. Oil extended declines to trade at seven week lows, while US Treasury yields have declined across the curve.
While a minor pullback in assets prices may be healthy given this year’s strong rally, it remains to be seen whether the coronavirus is just a speed bump in the global risk asset uptrend or the catalyst for a steeper decline. We should know the answer in a few days, probably mid-way into the Chinese New Year. Investors will be clearly monitoring how fast the virus is spreading, the mortality rate and when a cure is likely be found. In the meantime, expect to see volatility surging higher and further gains in safe havens such as Treasury Bonds and the Yen.
Disclaimer: The content in this article comprises personal opinions and should not be construed as containing personal and/or other investment advice and/or an offer of and/or solicitation for any transactions in financial instruments and/or a guarantee and/or prediction of future performance. ForexTime (FXTM), its affiliates, agents, directors, officers or employees do not guarantee the accuracy, validity, timeliness or completeness, of any information or data made available and assume no liability as to any loss arising from any investment based on the same.
US stock market closed mixed on Wednesday as in the first day of Senate impeachment trial most of the evidence being laid out was a rehash of testimony already presented in the House of Representatives. The S&P 500 inched up 0.03% to 3321.75. The Dow Jones industrial average however slipped 0.03% to 29186.27. Nasdaq added 0.14% to 9383.77. The dollar strengthening reversed despite report sales of existing homes surged nearly 4% in December. The live dollar index data show the ICE US Dollar index, a measure of the dollar’s strength against a basket of six rival currencies, declined 0.1% to 97.50 but is higher currently. Futures on stock indexes point to lower openings today.
CAC 40 led European indexes retreat
European stocks ended marginally lower on Wednesday as President Donald Trump threatened to impose tariffs on imports of cars from the European Union at the World Economic Forum in Davos. EUR/USD joined GBP/USD’s continued climb with both pairs lower currently. The Stoxx Europe 600 ended down 0.1% led by auto shares. Germany’s DAX 30 declined 0.3% to 13515.75. France’s CAC 40 fell 0.6% while UK’s FTSE 100 lost 0.5% to 7571.92.
Shanghai Composite Index led Asian indexes slump
Asian stock indices are solidly lower today as market participants try to gauge the impact of a flu epidemic after confirmation of the spread of the coronavirus in China. Nikkei fell 1% to 23795.44 as yen climb against the dollar continued despite report Japan’s exports fell 6.3% on year in December. Chinese stocks are down: the Shanghai Composite Index is down 3.4% while Hong Kong’s Hang Seng Index is 2.2% lower. Australia’s All Ordinaries Index lost 0.6% with Australian dollar climb against the greenback resuming after positive jobs report.
Brent futures prices are extending losses today. Prices fell on Wednesday: March Brent lost 2.1% to $63.21 on Wednesday. The American Petroleum Institute reported late Wednesday US crude oil supplies rose by 1.6 million barrels in the previous week. Shares of Saudi Aramco slipped 0.3% to 34.45 riyals per share. At the Saudi Arabia’s Finance Minister Mohammed Al-Jadaan said at Davos the kingdom is still considering listing shares abroad.
Gold weakening dynamic as Dollar strengthens resumes
Gold prices are edging lower as dollar inches up. The price of an ounce of gold for February delivery slipped 0.1% to $1,556.7 Wednesday as the dollar strengthening reversed.
Note: This overview has an informative and tutorial character and is published for free. All the data, included in the overview, are received from public sources, recognized as more or less reliable. Moreover, there is no guarantee that the indicated information is full and precise. Overviews are not updated. The whole information in each overview, including opinion, indicators, charts and anything else, is provided only for familiarization purposes and is not financial advice or а recommendation. The whole text and its any part, as well as the charts cannot be considered as an offer to make a deal with any asset. IFC Markets and its employees under any circumstances are not liable for any action taken by someone else during or after reading the overview.
Genprex’s shares spiked 380% higher in morning trading as the company reported that the FDA granted Fast Track Designation for its Oncoprex immunogene therapy in combination with EGFR inhibitor osimertinib.
This morning, Genprex Inc. (GNPX:NASDAQ), which “utilizes a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells,” announced that “the U.S Food and Drug Administration (FDA) has granted Fast Track Designation for Genprex’s Oncoprex immunogene therapy in combination with epidermal growth factor receptor (EGFR) inhibitor osimertinib (AstraZeneca’s Tagrisso®)” for the treatment of non-small cell lung cancer (NSCLC). According to the report, Tagrisso is AstraZeneca Plc’s (AZN:NYSE) highest grossing product, which had $2.31 billion in sales worldwide during the first nine months of 2019. The company reported that Oncoprex is composed of the active agent Tumor Suppressor Candidate 2 (TUSC2) gene complexed with a lipid nanoparticle.
The firm advised that it has already treated more than 50 lung cancer patients in total with Oncoprex in both phase 1 and phase 2 clinical trials and believes the trial data results are encouraging as to safety and efficacy. Genprex further indicated that it is currently preparing to initiate a phase 1/2 clinical trial in order to evaluate Oncoprex in combination with osimertinib and also a separate new phase 1 clinical trial evaluating Oncoprex in combination with a checkpoint inhibitor.
The company’s Chairman and CEO Rodney Varner commented, “Genprex is excited to receive this important FDA designation…In addition to potentially facilitating and expediting our pathway to approval, we believe that this FDA designation validates our plan to commercialize Oncoprex immunogene therapy in combination with EGFR inhibitors for the treatment of lung cancer. We hope that Fast Track Designation helps us bring our gene therapy to patients more rapidly and that our unique gene therapy platform is more widely recognized for its potential in cancer treatment.”
The firm explained “the FDA may award Fast Track Designation if it determines that a drug demonstrates the potential to address unmet medical needs for a serious or life-threatening disease or condition and that the provision is intended to facilitate development and expedite review of drugs to treat serious and life-threatening conditions so that an approved product can reach the market expeditiously.”
The company stated that the initial disease indication for Oncoprex is non-small cell lung cancer and advised that “lung cancer is the world’s leading cause of cancer death, taking more lives each year than colon, breast and prostate cancers combined.”
Genprex is a clinical-stage gene therapy company headquartered in Austin, Tex., that develops technologies for cancer patients using its proprietary technology platform. The company stated that “its lead product candidate, Oncopre immunogene therapy for NSCLC, has a multimodal mechanism of action whereby it has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells, re-establish pathways for apoptosis, or programmed cell death, in cancer cells, and modulate the immune response against cancer cells.”
Genprex began the day with a market capitalization of around $6.9 million with approximately 19.26 million shares outstanding. GNPX shares opened more than 230% higher today at $1.20 (+$0.84, +233.33%) compared to Friday’s $0.36 closing price. The stock has traded today on extremely high volume between $1.04 and $1.74 per share and is presently trading at $1.23 (+$0.87, +241.67%).
Disclosure: 1) Stephen Hytha compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. He or members of his household own securities of the following companies mentioned in the article: None. He or members of his household are paid by the following companies mentioned in this article: None. 2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees. 3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. 4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports. 5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. 6) This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. Readers should always contact their healthcare professionals for medical advice.
The next steps for the precious metals company are provided in a ROTH Capital Partners report.
In a Jan. 17 research note, analyst Jake Sekelsky reported that ROTH Capital Partners raised its price target on SilverCrest Metals Inc. (SIL:TSX.V) to $7.75 per share from $7.25. The current share price is $6.85. “Our increased valuation is primarily a reflection of rolling our model forward to 2020, coupled with the inclusion of the company’s financing announced in Q4/19,” he added.
Sekelsky noted that SilverCrest will be announcing in Q1/20 results from several hundred holes drilled at the Las Chispas property in 2019. It will include all results available through the end of Q1/20 into the upcoming feasibility study. After, it will likely shift focus “from infill drilling for the feasibility study to expansionary drilling at various targets across the company’s land package,” he added.
The analyst highlighted that with C$124 million in its treasury, SilverCrest is well funded for both exploration and development work this year. Its financial position also portends a positive production decision, expected around mid-2020. Accordingly, production could begin as soon as late 2021 but more conservatively in Q1/22.
Sekelsky commented, “2019 featured significant exploration success culminating in the establishment of what we view as a significant resource estimate at Las Chispas, which outlined over 100 million high-grade AgEq ounces. Despite this, we believe the surface has just been scratched as Las Chispas and expected 2020 to serve as a transformational year.”
Disclosure: 1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None. 2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees. 3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. 4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports. 5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases.
Disclosures from ROTH Capital Partners, SilverCrest Metals, Company Note, January 17, 2020
Regulation Analyst Certification (“Reg AC”): The research analyst primarily responsible for the content of this report certifies the following under Reg AC: I hereby certify that all views expressed in this report accurately reflect my personal views about the subject company or companies and its or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report.
Within the last twelve months, ROTH has received compensation for investment banking services from SilverCrest Metals.
ROTH makes a market in shares of SilverCrest Metals and as such, buys and sells from customers on a principal basis.
Shares of SilverCrest Metals may be subject to the Securities and Exchange Commission’s Penny Stock Rules, which may set forth sales practice requirements for certain low-priced securities.
ROTH Capital Partners, LLC expects to receive or intends to seek compensation for investment banking or other business relationships with the covered companies mentioned in this report in the next three months.
An update on the project and its production is provided in a Haywood report.
In a Jan. 10 research note, Haywood analyst Kerry Smith reported that Lundin Gold Inc. (LUG:TSX) remains on track and on budget to achieve commercial production at its Fruta del Norte project in Ecuador in Q2/20. “Fruta del Norte is one of only a few new large mines being built,” Smith highlighted.
Lundin poured first gold from the gravity circuit at Fruta del Norte on Nov. 16, 2019, after which it went on to produce 28,678 ounces of gold in 2019. Of those, 3,411 ounces were made into doré form, and the remaining 25,267 ounces were produced as a concentrate. Of the 3,400 tons of concentrate produced, 2,676 tons were shipped to a smelter in Finland.
Smith also reported on development progress of the mine and infrastructure. At year-end 2019, 13 kilometers of underground mine development were finished. Construction was 99.2% complete, and ore stockpiles amounted to 153,000 tons. Now, the water treatment plant is being commissioned. Boring of the south ventilation raise, in progress, is slated for completion in Q1/20. Lundin should get the paste plant and Zamora River bridge, which still need to be done, completed in Q2/20 and Q3/20, respectively.
The analyst pointed out that Lundin revised its life of mine plan for Fruta del Norte. It raised the all-in sustaining cost (AISC) by about 6.5% to US$621 per ounce from US$583; the new figure is lower than Haywood’s revised life of mine AISC of US$635 per ounce.
An increase in the assumed gold price to US$1,400 per ounce from US$1,250 drove the new AISC, which boosted production taxes and royalties and lowered projected byproduct credits.
“Gold prices are moving higher, and timing is looking good for this new producer,” commented Smith. Lundin is expected to produce 290,000 ounces of gold at Fruta del Norte in 2020.
Haywood has a Buy rating and a CA$9.25 per share target price on the company, whose stock is currently trading at around CA$9.42 per share.
Disclosure: 1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None. 2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees. 3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. 4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports. 5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases.
Disclosures from Haywood Securities, Lundin Gold Inc., January 10, 2020
Analyst Certification: I, Kerry Smith, hereby certify that the views expressed in this report (which includes the rating assigned to the issuers shares as well as the analytical substance and tone of the report) accurately reflect my/our personal views about the subject securities and the issuer. No part of my/our compensation was, is, or will be directly or indirectly related to the specific recommendations.
Important Disclosures
Of the companies included in the report the following Important Disclosures apply:
▪ Haywood Securities, Inc. has reviewed lead projects of Lundin Gold Inc. and a portion of the expenses for this travel have been reimbursed by the issuer. ▪ Haywood Securities, Inc. or one of its subsidiaries has managed or co-managed or participated as selling group in a public offering of securities for Lundin Gold Inc. in the last 12 months. Other material conflict of interest of the research analyst of which the research analyst or Haywood Securities Inc. knows or has reason to know at the time of publication or at the time of public appearance: n/a.